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Abstract
Objective: To identify associations between dietary glycaemic index (GI) and weight,
body mass index and other risk factors for cardiovascular disease (CVD) – waist-to-
hip ratio (WHR), lipoprotein fractions, triacylglycerols (TAG) and blood pressure (BP)
– in an older British population.
Design: Cross-sectional dietary, anthropometric and biochemical data from the
National Diet and Nutritional Survey for adults aged over 65 years were reanalysed
using a hierarchical regression model. Associations between body weight, CVD risk
factors, and dietary factors including GI and fibre intakes were explored among 1152
healthy older people living in the UK between 1994 and 1995.
Results: In the unadjusted model, GI was significantly and directly associated with
TAG (b ¼ 0.008 ^ 0.003) and diastolic BP (b ¼ 0.325 ^ 0.164) in males. These
relationships were attenuated and non-significant after adjustment for potential
confounding factors. WHR (b ¼ 0.003 ^ 0.001) and TAG (b ¼ 0.005 ^ 0.002) were
significantly predicted by GI in males and females combined. The association with
WHR was attenuated by adjustment for sex, age, region and social class; the
relationship with TAG was non-significant after adjustment for other potential dietary
confounders.
Conclusion: After controlling for potential confounders, no clear links were detected
between GI and body weight or other CVD risk factors. This study provides little
evidence for advising the consumption of a low-GI diet in the elderly to prevent
weight gain or improve other CVD risk factors.
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The 2003 World Health Report attributes 29.2% of global
deaths to cardiovascular disease (CVD)1. Overall, CVD is
estimated to cost the UK close to £26 billion per year: 56%
from direct health-care costs, 24% from reduced pro-
ductivity and 16% as a result of informal care2. Advancing
age is the principal non-modifiable risk factor for this
disease3 and, given that the UK population is ageing4,
research efforts must focus on primary prevention to
tackle the growing public health burden. High blood
pressure (BP), smoking and high total cholesterol (TC)
levels are the principal modifiable risk factors for CVD
mortality5, although risk is not limited to these factors.
A wealth of evidence is available describing the CVD
risk attributable to adiposity (estimated, for example,
using body mass index (BMI; kg m22)6 or waist-to-hip
ratio (WHR)7); serum TC, low-density lipoprotein
cholesterol (LDL-C)8 and high-density lipoprotein choles-
terol (HDL-C)9; serum triacylglycerols (TAG)10; and dietary
fats11,12. Less is known about the potential role of dietary
carbohydrate13.
The glycaemic index (GI) ranks carbohydrate-contain-
ing foods based on the increase in blood glucose
following their consumption relative to that following
consumption of an equi-carbohydrate portion of a
reference food (white bread or glucose)14. This index is
therefore more informative than measuring the quantity of
carbohydrate consumed alone. The exaggerated glucose
and insulin responses that occur when consuming a high-
GI diet could increase the risk of CVD via a number of
mechanisms. These include oxidative stress as a result of
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postprandial hyperglycaemia and independent effects of
hyperinsulinaemia on lipid profile, blood pressure,
coagulation factors, inflammatory mediators and endo-
thelial function15.
Table 116–29 summarises previous research investigating
the relationship between GI and CVD risk factors. Two
publications have reviewed the efficacy of low-GI diets for
weight loss; however their conclusions differ, highlighting
the controversy surrounding low-GI diets. Raben18
concluded that there was no evidence to support the use
of low-GI diets for long-term weight control. Of the 20
longer-term studies reviewed (duration ranging from 6
days to 6 months) mean weight loss was 1.5 kg on the low-
GI diets compared with 1.6 kg (not significant, NS) on the
high-GI diets. When including only the nine studies that
were well-controlled for energy, macronutrient and fibre
intake, the mean weight loss was greater on the low-GI
diets (23.0 ^ 1.8 vs. 22.8 ^ 1.1 kg, NS). This latter
finding echoes those reported by Brand-Miller et al.9.
Four medium-term (duration range 5–18 weeks) human
intervention studies were examined, with two demonstrat-
ing greater weight or fat loss on low- vs. high-GI diets and
two showing no significant difference. Findings from
animal models that support a beneficial role of low-GI
diets for weight loss were also included. For example, rats
fed a diet based on high-GI starch, but otherwise matched
for energy and macronutrient intakes, had increased
visceral fat stores and reduced rates of lipolysis30. Brand-
Miller et al.19 suggested that animal studies provide
mechanistic evidence and contradict the assumption that
all calories are equal in terms of effect on weight gain.
Suggestive evidence is available from well-controlled,
sufficiently powered studies to suggest that decreased
dietary GI is associated with a reduced risk from CVD;
however, as reasoned in both review articles, longer-term
randomised controlled trials (RCTs) are necessary to
elucidate this relationship in different population groups
and to investigate the effects of conventional energy-
restricted vs. ad libitum low-GI diets on weight loss for
example.
A 10% reduction in LDL-C (P , 0.05)21, elevations in
HDL-C (0.08–0.25 mmol l21 greater in the lowest quintile,
P , 0.05)23,26 and reductions in TAG (237.2 vs. 219.1%,
P ¼ 0.005)22 have been observed with low- vs. high-GI
diets. Two meta-analyses (of 15 and 16 RCTs, respectively)
examining the effects of low-GI diets on blood lipid levels
found evidence for a beneficial effect of low-GI diets on
TC and limited evidence for a reduction in LDL-C in
subjects with type 2 diabetes. No benefit was observed for
either HDL-C or TAG16,17. However, many of the studies
reviewed were methodologically flawed, under-powered
or of short duration.
No standard definitions exist to quantify ‘low’- and
‘high’-GI diets, although a difference of at least 10–15
units is observed in most publications17. Between-study
differences in these definitions may contribute to the
inconsistent results of clinical trials to date. Many low-GI
foods (e.g. granary bread, pasta, beans and pulses) are
high in fibre and inadequate control for differences in fibre
intake – a potentially cardioprotective factor31,32 – may
confound studies of dietary GI and cardiovascular
health33. The glycaemic load (GL), calculated as total
amount of daily carbohydrate (g) £ GI, is a measure of the
overall postprandial glycaemic effect of a food or meal.
High-GL diets have also been associated with an increased
risk of coronary heart disease (CHD)24 and detrimental
effects on CVD risk factors29. In the current study the effect
of GI alone is examined. Relationships between other
carbohydrate-related dietary variables (fibre, GL, carbo-
hydrate intake) and CVD risk factors are currently being
analysed for this cohort and will be the subject of future
publications.
Evidence for an association between dietary GI and
CVD risk in free-living settings is conflicting, and data are
particularly limited in elderly populations. Here, data from
the National Diet and Nutrition Survey of adults aged 65
years and over (referred to hereafter as NDNS) are
examined to determine if low dietary GI is associated with
lower body weight, BMI, WHR, BP and a more favourable
serum cholesterol profile.
Subjects and design
The NDNS34 is a comprehensive, cross-sectional survey
which collected data on dietary habits and nutritional
status. All individuals who agreed to participate completed
a descriptive interview detailing general eating habits,
medications, socio-economic and health status before they
were invited to take part in further data collection. All
subsequent interviews (e.g. 4-day weighed intake record,
blood and urine collections) were optional. Only data
collected from free-living, non-institutionalised partici-
pants are considered here; no subjects were following a
weight-loss diet at the time of the survey.
NDNS methods are reported in detail elsewhere34.
Briefly, anthropometric measurements were carried out at
the participant’s home, with their shoes removed, wearing
light clothing. Height was measured to the nearest 1 mm
using a portable, digital telescopic stadiometer; weight to
the nearest 100 g using Soehnle Quantratronic digital
scales. BMI was calculated as weight (kg) divided by the
square of height (m2)35. Duplicate waist and hip
measurements were made using an insertion tape, and
WHR was calculated from the mean of two readings. Three
supine BP measurements were taken from the right arm at
intervals of 1 min using an automated sphygmoman-
ometer (DINAMAP; GE Health Systems). Blood samples
were collected after an overnight fast and analysed for TC,
HDL-C, LDL-C and TAG concentrations34.
Participants were issued with Soehnle Quanta digital
food scales and two 4-day dietary record sheets: one for use
at home and a simplified form for use outside home.
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Table 1 Summary of previous research investigating the relationship between GI and CVD risk factors
Study category Study type
Author
and date
Number of
subjects
Subject
characteristics
Outcome
measure(s)
Intervention
period
Difference in GI,
mean (SD)
or range Results Significance
Intervention Meta-analysis Opperman
et al. (2004)16
396 Adults with T1DM (105) Change in fructosamine,
HbA1c, HDL-C, LDL-C,
TC and TG conc
12 days to
6 months
24 (9) units # in fructosamine in low-GI
groups (20.1 mmol l21)
P ¼ 0.05
Adults with T2DM (228) 21 (7) units # in HbA1c in low-GI
groups (20.27%)
P ¼ 0.03
Healthy adults (17) 22 (9) units No difference in HDL-C conc
(20.03 mmol l21)
P ¼ 0.23
Adults with CHD (46) 21 (10) units # in LDL-C conc in low-GI
groups (20.15 mmol l21)
P ¼ 0.06
22 (8) units # in TC conc in low-GI
groups (20.33 mmol l21)
P , 0.001
20 (9) units No difference in TG conc
(0.03 mmol l21)
P ¼ 0.73
Meta-analysis Kelly et al.
(2004)17
325 Adults with at least
1 major risk factor for
CHD or diagnosed
with CHD
Change in weight, fasting
glucose, fasting insulin,
TC, HDL-C, LDL-C, TG
and HbA1c conc
4 weeks to
6 months
5 to 32 units Pooled # in TC of 20.17mmol l21
for the low- vs. the high-GI group
P ¼ 0.03
No difference in change in HDL-C
between diets
No difference in change
in LDL-C between diets
No difference in change
in TG conc between diets
No difference in change
in body weight between diets
No difference in change in fasting
glucose, fasting insulin or
HbA1c between diets
Review – medium-
term human studies
Raben (2002)18 538 Normal weight, overweight
or obese children and adults
Change in weight 6 days to
6 month
Not provided No difference in mean weight loss
between low- and high-GI diets
(21.5 kg vs. 21.6 kg)
P . 0.05
Review – medium-
term human
studies
Brand-Miller
et al. (2002)19
170 Overweight or
obese children
and adults
Change in weight,
WC, fat mass
5 weeks to
4 months
Not provided 3 of 4 studies observed a greater #
in weight, BMI or fat mass on
low- vs. high-GI diets
P , 0.05
1 of 4 showed no difference
in weight loss between diets
P . 0.05
Meta-analysis Brand-Miller
et al. (2003)20
356 Adults with T2DM Change in HbA1c and
fructosamine conc
12 days to
12 months
Not provided Low-GI diets reduced HbA1c
by 0.43% points more
than high-GI diets
P , 0.05
Low-GI diets reduced glycated
proteins (HbA1c and fructosamine)
by 7.4% more than high-GI diets
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Table 1. Continued
Study category Study type
Author
and date
Number of
subjects
Subject
characteristics
Outcome
measure(s)
Intervention
period
Difference in GI,
mean (SD)
or range Results Significance
Parallel randomised
study
Sloth et al.
(2004)21
45 Healthy overweight
females
Change in weight,
fat mass, fasting
insulin, insulin
resistance, b- cell
function, NEFA,
TC, HDL-C,
LDL-C and TG conc
10 weeks 17 units for
test foods
provided
No difference in change in
weight or fat mass
between diets
P . 0.05
No difference in fasting insulin,
insulin resistance, b-cell function,
TG, NEFA or HDL-C conc
P . 0.05
Greater # in LDL-C on ow-GI diet P , 0.05
Greater # in TC on low-GI diet P ¼ 0.06
Parallel
randomised study
Ebbeling et al.
(2005)22
23 Healthy obese
young adults
Weight, TG, PAI-1,
TC, insulin
sensitivity, BP
12 months 6.6 units at
12 months
No difference in change in
weight between diets
P . 0.05
No difference in change in
TG, PAI-1, TC, insulin
sensitivity or BP
P . 0.05
Greater # in TG concentration
in low-GI group (237.2%
vs. 219.1%)
P ¼ 0.005
PAI-1 # in intervention group
(239.0%) and " in the
conventional group (33.1%)
P ¼ 0.004
Epidemiological Cross-sectional
study
Frost et al.
(1999)23
1420 Healthy adults TC, HDL-C and
LDL-C conc
N/A N/A Inverse relationship between
GI and HDL-C
P ¼ 0.02 for males,
P , 0.0001 for
females
No significant relationship between
GI and TC or LDL-C
Prospective
study, 10-year
follow-up period
Liu et al.
(2000)24
75 521 Healthy
adult females
CHD incidence N/A N/A Direct relationship between
GL and CHD risk
P , 0.0001 for
linear trend
Prospective study,
10-year follow-up
period and cross-
sectional study
van Dam
et al. (2000)25
646
(prospective);
394 (cross-
sectional)
Elderly males CHD incidence;
metabolic risk
factors
N/A N/A No relationship between
GI and CHD risk
P ¼ 0.70 for
linear trend
No relationship between
GI and TC, HDL-C, TG,
(fasting or post-load)
glucose or insulin conc
Cross-sectional
study
Ford & Liu
(2001)26
13 907 Healthy adults HDL-C conc N/A N/A Inverse relationship between
GI/GL and HDL-C
P , 0.001 for
linear trend
15-unit " in GI associated
with a # in HDL-C of
0.06 mmol l21
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Table 1. Continued
Study category Study type
Author
and date
Number of
subjects
Subject
characteristics
Outcome
measure(s)
Intervention
period
Difference in GI,
mean (SD)
or range Results Significance
1-year longitudinal
analysis
Ma et al.
(2005)47
572 Healthy
adults
Change in BMI N/A N/A Direct relationship between
GI and BMI
Cross-sectional:
P ¼ 0.01
5-unit " in GI associated
with " of 0.75 BMI units
from cross-sectional
data and " of 0.04 units
from longitudinal data
Longitudinal:
P ¼ 0.02
Cross-sectional
study
Liese et al.
(2005)28
979 Healthy adults
(66%), IGT
adults (33%)
Insulin sensitivity,
fasting insulin,
acute insulin
response, disposition
index, BMI and WC
N/A N/A No relationship between GI
and any outcome variable
P . 0.05
Cross-sectional
study
Slyper et al.
(2005)29
32 Healthy subjects
aged 11–25
years
TC, HDL-C
and LDL-C
N/A N/A Inverse relationship between
GL and HDL-C
P , 0.05
GI – glycaemic index; CVD – cardiovascular disease; SD – standard deviation; T1DM – type 1 diabetes mellitus; T2DM – type 2 diabetes mellitus; CHD – coronary heart disease; IGT – impaired glucose tolerance;
HbA1c – glycated haemoglobin; HDL-C – high-density lipoprotein cholesterol; LDL-C – low-density lipoprotein cholesterol; TC – total cholesterol; TG – triglycerides; conc – concentration(s); WC – waist circumfer-
ence; NEFA – non-esterified fatty acids; PAI-1 – plasminogen-activator inhibitor-1; BP – blood pressure; BMI – body mass index; N/A – not applicable; # , decrease; " , increase; GL – glycaemic load.
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A description/brand of all food and drink consumed at
home was recorded alongside the weight of food served
and any leftovers. For food consumed away from home –
where weighing was inconvenient – participants recorded
a description, price and place of purchase. Trained
interviewers then purchased and weighed the items. The
feasibility study revealed significant differences in nutrient
intake between different days of the week, so a diary
placement pattern (i.e. completing a set number or
proportion of diaries on each day of the week) was used
in the final survey to ensure that, for example, weekday vs.
weekend variation in intakes was accounted for36. Details
from both diaries were matched to nutrient composition
information (55 nutrients) using a nutrient databank of over
3500 foods, compiled by the Ministry of Agriculture,
Fisheries and Foods37.
GI calculation
A GI value (reference food ¼ glucose) was added to the
NDNS database for each of the 2323 carbohydrate-
containing food codes recorded in the diet diaries.
Values were obtained from the international table of GI
and GL values38 and other published sources39,40, using
means of multiple entries when available. Where no
published data were available, published analogues
were used (for example, the mean GI value for
‘oranges’ was imputed for ‘clementines’) or GI values
were calculated from recipes using the mixed-meal
formula41:
To calculate the average GI of each diet, the following
formula was applied42:
GIdiet ¼
food
XGIfood£Quantityof carbohydrateinthefood ðgÞ
Totalquantityof carbohydrateinthedietðgÞ :
Many of the foods for which GI values were estimated
contributed only a small proportion of the total
carbohydrate consumed by each individual. To assess
the relative importance of GI values obtained from various
sources, the mean percentage of an individual’s total
carbohydrate intake attributable to each source of GI data
(international tables, other published data, estimations
and calculations) was calculated.
Validation of dietary intake
Basal metabolic rate (BMR), calculated using standard
regression equations based on age, sex and weight
(Schofield equations)43, was compared with energy intake
to identify underreporting. A habitual energy intake estimate
less than 1.2 £ BMR, considered incompatible with energy
balance44, was used here to define low energy reporters
(LERs). In the feasibility study, a 24-hour urine sample was
taken and p-aminobenzoic acid tablets were given to
participants to check the completeness of the sample.
Protein intakes were validated by comparing urinary and
dietary nitrogen (N) concentration: ratios of urinary N/
dietary N were 0.92 for males and 0.87 for females, close to
the permitted range for validity (0.70–0.90)36.
Statistical analysis
To control for the potentially confounding effect of energy
intake, all nutrient data are presented as energy-adjusted
variables. HDL-C, TC/HDL-C ratio, TAG and Englyst fibre
intake were log-transformed to normalise the distributions.
The ratio of polyunsaturated to saturated fatty acid intake
(P/S) was calculated and used in subsequent analyses to
improve the stability of the regression model. Differences in
means between LERs and non-LERs and between males and
femaleswere compared with unpaired t-tests for continuous
variables and by x2 tests for categorical variables.
To inform regression analyses and identify potential
collinearity, a Spearman correlation matrix, controlled for
energy intake (males and females separately and
combined), was constructed for nutrient and physical
activity level (PAL) data.
Associations of GI with CVD risk factors (weight,
n ¼ 993; BMI, n ¼ 983; WHR, n ¼ 993; BP, n ¼ 960;
lipoprotein sub-fractions, n ¼ 784; TAG, n ¼ 1100) were
analysed using multiple linear regression. The basic model
for all dependent variables was adjusted for age, region
and social class (non-manual or manual, classified by main
occupation prior to retirement). Analyses were carried out
separately for males and females and combined (with
adjustment for sex in combined analysis).
Evidence-based confounding factors were added
sequentially in additional models for each dependent
variable (e.g. BMI when BP was the dependent)45. In
subsequent models, reported potential confounders were
also added (e.g. P/S ratio when BP was the dependent)46.
To determine if the amount of fibre consumed affected the
relationship of dietary GI to the dependent variables, an
interaction term (GI £ Englyst fibre) was included in
additional regression models.
All analyses were performed with SPSS (version 12.0;
SPSS Inc.). Analyses were carried out on the full sample
and repeated with the exclusion of LERs. P-values
,0.05 (two-tailed) were considered statistically
significant.
GIfood ¼
ingredient
XGIingredient £Quantity of carbohydrate in the ingredient ðgÞ
Total quantity of carbohydrate in the food ðgÞ :
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Results
Study population
Of the free-living sample (n ¼ 2172 individuals), 75%
(n ¼ 1632) provided a full or partial interview (responding
sample) and 78% (n ¼ 1275) of the responding sample
also provided a 4-day weighed dietary intake record. Data
collected from those who reported being unwell during
the dietary recording period, with appetite/eating patterns
affected (8% males, n ¼ 50; 11% females, n ¼ 73), were
excluded. This resulted in a maximum study population of
1152 individuals (53% of the initial sample), of which
50.5% were male (age 75.9 ^ 7.0 years, BMI
26.3 ^ 3.6 kg m22; mean ^ standard deviation, SD) and
49.5% were female (age 77.6 ^ 8.0 years, BMI
26.6 ^ 4.8 kg m22; mean ^ SD). Selected demographic,
lifestyle, anthropometric, biochemical and nutrient charac-
teristics are presented by sex in Table 2. Some 49.2%
(n ¼ 478) of individuals (39.7% males, 59.4% females;
P , 0.001) were defined as LERs. The exclusion of these
participants did not materially affect the outcomes, and
thus only the analyses performed on the full dataset are
presented.
Source of GI values
GI values were assigned to 2323 individual food codes,
contributing 73% of the total weight of carbohydrate
consumed by participants. Of these, 235 (10%) were
assigned a mean value from multiple entries in the
international tables, and 358 (15%) were obtained from a
single entry in the international tables38. Values for 1580
(68%) codes were estimated from analogous foods with
published GI values, while 96 (4%) were calculated by the
mixed-meal method42. The 54 remaining GI values were
sourced from other published data39,40. On average, GI
values assigned from a mean value from the international
tables contributed 43.5 ^ 14.2% (mean ^ SD) of an
individual’s total carbohydrate intake; values obtained
from a single entry 24.7 ^ 13.0%; analogues 26.3 ^ 11.7%;
and mixed-meal calculated GI values 1.8 ^ 3.3%. The
remaining GI values, obtained from other published
sources39,40, contributed on average 3.5 ^ 3.4% of total
carbohydrate intake.
Correlation analyses
Correlation matrices for males and females are presented
in Tables 3 and 4, respectively. Dietary GI did not correlate
significantly with weight, BMI, WHR, BP or any lipoprotein
fraction in either sex. Dietary GI was inversely associated
with Englyst fibre intakes in males and females (r ¼ 20.34
and r ¼ 20.32, respectively).
Regression analyses
Associations of dietary GI with weight, BMI, WHR and
other CVD risk factors, with and without control for
potential confounders, are reported for males and females
in Tables 5 and 6, respectively.
In males, prior to controlling for potential confounders,
dietary GI was directly associated with 10g TAG
concentration (b ¼ 0.008 ^ 0.003). There was also a
direct relationship between GI and diastolic BP
(b ¼ 0.325 ^ 0.164). However, after adjusting for age,
social class and region (Model 2), neither association was
statistically significant. In females, dietary GI was not
significantly associated with any of the anthropometric
variables or CVD risk factors assessed, either before or
after adjustment for confounders.
When the analyses were repeated in males and females
combined (data not shown), WHR was significantly
predicted by dietary GI (b ¼ 0.003 ^ 0.001; P , 0.001)
in Model 1. However, after controlling for sex, age, social
class and region, the relationship was no longer
significant. Subsequent models further reduced the
strength of the relationship. Dietary GI predicted (log)
TAG concentration (b ¼ 0.005 ^ 0.002; P ¼ 0.017); the
association remained significant after control for sex, age,
social class and region (Model 2), and PAL and BMI (Model
3) (b ¼ 0.004 ^ 0.002; P ¼ 0.049). Adjusting for alcohol
(units week21) (Model 4), carbohydrate (g day21) (Model
5) and Englyst fibre (g day21) (Model 6) weakened the
association (b ¼ 0.02 ^ 0.02; P ¼ 0.362), which became
non-significant.
When the interactions between fibre and GI were
considered, it was apparent that in females the non-
significant relationships between dietary GI and weight
and between dietary GI and BMI were dependent on fibre
intake. The addition of a GI £ fibre interaction term to the
regression model revealed significant inverse associations
between GI and weight (b ¼ 20.995 ^ 0.360; P ¼ 0.008)
and GI and BMI (b ¼ 20.302 ^ 0.145; P ¼ 0.038).
Significant and borderline-significant interactions were
detected between fibre and GI in males for HDL-C,
TC/HDL-C ratio and TAG, indicating that the observed
relationships (non-significant) of dietary GI and these
outcome measures are also dependent on fibre intake.
Discussion
Carbohydrate is absorbed rapidly from high-GI (relative to
low-GI) foods, causing higher postprandial glucose and
insulin responses47. This encourages carbohydrate rather
than fat oxidation, stimulates lipolysis and increases
visceral non-esterified fatty acid release in the late
postprandial period, promoting body fat gain. Low-GI
carbohydrates have been associated with greater satiety
and hence reductions in subsequent energy intake48.
Thus, we hypothesised that low-GI diets would be
associated with lower body weight, BMI, WHR, BP and a
more favourable cholesterol profile in a free-living
population. Our study found a high-GI diet to be
associated with higher TAG concentrations and higher
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Table 2 Demographic, lifestyle, anthropometric, biochemical and dietary intake data by sex for all participants (all significant differences
are highlighted)
Males Females
Demographics
Region
Scotland and Northern 34.4 34.9
Central and South West 42.1 37.5
London and South East 23.5 27.5
Social class
Non-manual 45.1 46.6
Manual 54.9 53.4
Age (years) 75.9 ^ 7.0* 77.6 ^ 8.0
Lifestyle
Smoking status
Non (never & ex) 82.9 87.5
, 20 cigarettes day21 11.0 10.2
$ 20 cigarettes day21 6.0 2.3
Self-reported alcohol intake level
Non-drinker 7.2 25.3
Ex-drinker 10.8 8.2
Very low 11.5 20.5
Low 35.5 31.1
Moderate 16.2 6.8
Fairly high 8.3 4.0
High 4.5 0.9
Very high 2.6 0.4
Drinker, units unknown 3.4 2.8
Estimated alcohol intake (units week21) 10.5 ^ 15.0** 3.0 ^ 5.0
Maximum physical activity level
Vigorous (e.g. running or jogging) 0.5 0.4
Moderate (e.g. cycling, keep fit, swimming, $20 min brisk walking) 79.7 85.4
Light (e.g. dancing, golf, yoga, $20 min slow walking) 18.4 13.5
Inactive 1.4 0.7
BMR 1521.5 ^ 157.1** 1263.6 ^ 121.4
EI/BMR ratio 1.26 ^ 0.30** 1.13 ^ 0.27
Anthropometry
Height (cm) 169.0 ^ 6.9** 155.4 ^ 6.7
Weight (kg) 75.1 ^ 12.0** 64.1 ^ 12.4
BMI (kg m22) 26.3 ^ 3.6 26.6 ^ 4.8
WHR 0.93 ^ 0.06** 0.84 ^ 0.07
Blood pressure
Systolic (mmHg) 150.1 ^ 21.9* 154.5 ^ 23.8
Diastolic (mmHg) 79.7 ^ 12.7* 76.7 ^ 13.5
Biochemical
TC (mmol l21) 5.5 ^ 1.1** 6.3 ^ 1.5
TAG (mmol l21) 1.6 ^ 0.9 1.6 ^ 0.8
HDL-C (mmol l21) 1.2 ^ 0.5** 1.4 ^ 0.5
LDL-C (mmol l21) 4.3 ^ 1.2** 4.9 ^ 1.5
Dietary intake
Energy intake (kcal) 1891.2 ^ 454.8** 1415.3 ^ 338.0
CHO (% of food energy) 49.1 ^ 7.0 49.4 ^ 6.3
Starch (% of food energy) 27.2 ^ 5.8 27.3 ^ 5.3
Sugar (% of food energy) 22.0 ^ 7.1 22.0 ^ 6.8
Englyst fibre (g per 1000 kcal) 7.1 ^ 2.8** 7.7 ^ 3.1
Protein (% of food energy) 15.1 ^ 3.0** 15.9 ^ 3.6
Fat (% of food energy) 35.0 ^ 5.7** 36.7 ^ 6.2
SFA (% of food energy) 14.5 ^ 3.6** 15.8 ^ 4.1
MUFA (% of food energy) 10.8 ^ 2.0 11.0 ^ 2.1
n–3 PUFA (% of food energy) 0.77 ^ 0.36* 0.82 ^ 0.36
n–6 PUFA (% of food energy) 4.8 ^ 2.1 4.8 ^ 2.2
P/S ratio 0.42 ^ 0.22 0.40 ^ 0.24
TFA (% of food energy) 1.5 ^ 0.5** 1.6 ^ 0.5
GI 59.4 ^ 3.6** 58.2 ^ 3.8
BMR – basal metabolic rate; EI – energy intake; BMI – body mass index; WHR – waist-to-hip ratio; TC – total cholesterol; TAG – triacylglycerols; HDL-C
– high-density lipoprotein cholesterol; LDL-C – low-density lipoprotein cholesterol; CHO – carbohydrate; SFA – saturated fatty acids; MUFA – monounsatu-
rated fatty acids; PUFA – polyunsaturated fatty acids; P/S ratio – polyunsaturated fat/saturated fat; TFA – trans fatty acids; GI – glycaemic index.
Data are presented as % (categorical variables) or mean ^ standard deviation (continuous variables).
Significant difference between males and females (unpaired Student’s t-test for continuous variables, x2 test for categorical variables): *P , 0.05,
** P , 0.01.
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Table 3 Correlation matrix of nutrient variables for males controlled for energy intake (kcal)
CHO (g) Sugar (g) Starch (g)
Englyst
fibre (g) Protein (g) Fat (g) SFA (g) MUFA (g) n–3 PUFA (g) n–6 PUFA (g) P/S ratio TFA (g) Chol (mg) EtOH (units week21) PAL
GI 0.01 20.16** 0.20** 20.34** 20.17** 20.04 20.06 20.02 20.02 0.04 0.07 0.00 0.00 0.06 0.04
CHO (g) 0.67** 0.43** 0.26** 20.16** 20.45** 20.34** 20.48** 20.18** 20.03 0.09* 20.04 20.34** 20.46 0.03
Sugar (g) 20.38** 20.05 20.35** 20.42** 20.18** 20.44** 20.26** 20.24** 20.12** 20.09* 20.20** 20.19** 0.04
Starch (g) 0.39** 0.22** 20.05 20.22** 20.05 0.08* 0.26** 0.27** 0.06 20.19** 20.34** 20.01
Englyst fibre (g) 0.35** 20.15** 20.24** 20.16** 0.13** 0.19** 0.25** 20.17** 20.18** 20.17** 20.11**
Protein (g) 0.02 20.07 0.06 0.27** 0.06 0.08* 20.12** 0.25** 20.09* 20.06
Fat (g) 0.78** 0.86** 0.19** 0.24** 20.12** 0.52** 0.33** 20.27** 0.07
SFA (g) 0.53** 20.09* 20.33** 20.63** 0.48** 0.34** 20.21** 0.07
MUFA (g) 0.28** 0.18** 20.07 0.40** 0.33** 20.15** 0.06
n–3 PUFA (g) 0.16** 0.26** 20.04 0.03 20.02 20.06
n–6 PUFA (g) 0.85** 20.08* 20.17** 20.14** 20.02
P/S ratio 20.29** 20.23** 20.01 20.06
TFA (g) 0.15** 20.31** 0.03
Chol (mg) 0.00 0.09*
EtOH (units week21) 20.02
CHO – carbohydrate; SFA – saturated fatty acids; MUFA – monounsaturated fatty acids; PUFA – polyunsaturated fatty acids; P/S ratio – polyunsaturated fat/saturated fat; TFA – trans fatty acids; Chol – cholesterol;
EtOH – alcohol; PAL – physical activity level; GI – glycaemic index.
Significant correlation: *P , 0.05, **P , 0.01.
Table 4 Correlation matrix of nutrient variables for females controlled for energy intake (kcal)
CHO (g) Sugar (g)
Starch
(g)
Englyst
fibre (g) Protein (g) Fat (g) SFA (g)
MUFA
(g)
n 2 3 PUFA
(g)
n 2 6 PUFA
(g) P/S ratio TFA (g) Chol (mg)
EtOH
(units week21) PAL
GI 2 0.01 2 0.32** 0.39** 2 0.32** 2 0.18** 0.11* 0.00 0.17** 0.05 0.10* 0.09* 0.09* 0.04 2 0.05 0.01
CHO (g) 0.67** 0.34** 0.22** 2 0.24** 2 0.77** 2 0.53** 2 0.68** 2 0.23** 2 0.16** 0.07 2 0.25** 2 0.52** 2 0.18** 0.06
Sugar (g) 2 0.47** 0.07 2 0.22** 2 0.51** 2 0.20** 2 0.52** 2 0.25** 2 0.29** 2 0.14** 2 0.23** 2 0.24** 2 0.05 0.06
Starch (g) 0.16** 0.00 2 0.26** 2 0.37** 2 0.15** 0.04 0.17** 0.26** 0.00 2 0.31** 2 0.15** 0.00
Englyst fibre (g) 0.36** 2 0.38** 2 0.35** 2 0.36** 0.11* 0.09* 0.27** 2 0.28** 2 0.22** 2 0.03 2 0.06
Protein (g) 2 0.28** 2 0.30** 2 0.17** 0.15** 0.04 0.21** 2 0.32** 0.22** 0.04 2 0.10*
Fat (g) 0.76** 0.84** 0.14** 0.15** 2 0.20** 0.50** 0.40** 2 0.16** 0.01
SFA (g) 0.44** 2 0.16** 2 0.43** 2 0.68** 0.43** 0.34** 2 0.13** 0.05
MUFA (g) 0.27** 0.17** 2 0.08 0.42** 0.37** 2 0.11* 2 0.03
n 2 3 PUFA (g) 0.23** 0.31** 2 0.10* 0.12* 0.06 2 0.09*
n 2 6 PUFA (g) 0.84** 2 0.15** 2 0.11* 2 0.02 2 0.04
P/S ratio 2 0.31** 2 0.17** 0.05 2 0.06
TFA (g) 0.12** 2 0.14** 0.03
Chol (mg) 0.00 0.02
EtOH (units week21) 0.08
CHO – carbohydrate; SFA – saturated fatty acids; MUFA – monounsaturated fatty acids; PUFA – polyunsaturated fatty acids; P/S ratio – polyunsaturated fat/saturated fat; TFA – trans fatty acids; Chol – cholesterol;
EtOH – alcohol; PAL – physical activity level; GI – glycaemic index.
Significant correlation: *P , 0.05, **P , 0.01.
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Table 5 Results of the linear regression analysis of GI and CVD risk factors in males
Model 1† Model 2‡ Model 3 Model 4 Model 5 Model 6
B ^ SE P B ^ SE P B ^ SE P B ^ SE P B ^ SE P B ^ SE P
Weight§ 0.004 ^ 0.151 0.98 20.085 ^ 0.149 0.57 20.077 ^ 0.149 0.60 20.084 ^ 0.149 0.58 20.054 ^ 0.157 0.73
BMI§ 0.008 ^ 0.046 0.86 20.030 ^ 0.046 0.52 20.031 ^ 0.046 0.51 20.032 ^ 0.047 0.49 20.005 ^ 0.049 0.92
WHR§ 0.001 ^ 0.001 0.09 0.001 ^ 0.001 0.29 0.001 ^ 0.001 0.33 0.001 ^ 0.001 0.31 0.001 ^ 0.001 0.30
TC{ 20.003 ^ 0.016 0.84 20.010 ^ 0.017 0.55 20.005 ^ 0.017 0.75 20.005 ^ 0.017 0.75 0.000 ^ 0.017 0.99 20.008 ^ 0.017 0.63
LDL-C{ 0.000 ^ 0.016 0.99 20.008 ^ 0.017 0.63 20.005 ^ 0.017 0.78 20.005 ^ 0.017 0.75 20.002 ^ 0.017 0.88 20.009 ^ 0.018 060
þ HDL-Ck 20.003 ^ 0.002 0.21 20.002 ^ 0.002 0.36 20.001 ^ 0.02 0.52 20.002 ^ 0.002 0.35 20.001 ^ 0.002 0.49 20.001 ^ 0.002 0.57
þ TC/HDL-C ratiok 0.002 ^ 0.002 0.44 ,0.001 ^ 0.002 0.90 ,0.001 ^ 0.002 0.99 0.001 ^ 0.002 0.81 ,0.001 ^ 0.002 0.91 0.001 ^ 0.002 0.91
þ TAG†† 0.008 ^ 0.003 0.02* 0.006 ^ 0.003 0.07 0.005 ^ 0.003 0.10 0.005 ^ 0.003 0.12 0.005 ^ 0.003 0.13 0.003 ^ 0.003 0.35
SBP‡‡ 0.409 ^ 0.278 0.14 0.246 ^ 0.287 0.39 0.261 ^ 0.288 0.37 0.219 ^ 0.288 0.45 0.184 ^ 0.290 0.52 0.073 ^ 0.306 0.81
DBP‡‡ 0.325 ^ 0.164 0.05* 0.164 ^ 0.167 0.33 0.180 ^ 0.167 0.28 0.159 ^ 0.167 0.34 0.148 ^ 0.168 0.38 0.026 ^ 0.177 0.88
GI – glycaemic index; CVD – cardiovascular disease; SE – standard error; BMI – body mass index; WHR – waist-to-hip ratio; TC – total cholesterol; LDL-C – low-density lipoprotein cholesterol; HDL-C – high-
density lipoprotein cholesterol; TAG – triacylglycerols; SBP – systolic blood pressure; DBP – diastolic blood pressure.
þ indicates dependent variables that were log-transformed to normalise before use in regression analysis.
* Significant at P , 0.05.
† Model 1 shows unadjusted influence of GI on dependent variable.
‡ Model 2, for all variables, is adjusted for age, social class and region.
§ For weight, BMI and WHR, Model 3 is adjusted for physical activity and energy intake; fat (g day21) is added to Model 4; and Englyst fibre (g day21) to Model 5.
{For TC and LDL-C, Model 3 is adjusted for physical activity, energy intake and BMI; Model 4 is additionally controlled for fat intake (g day21); smoking, polyunsaturated fat/saturated fat ratio, cholesterol intake
(mg day21) and trans fatty acids (g day21) are added in Model 5; and Engylst fibre (g day21) in Model 6.
kHDL-C and TC/HDL-C ratio are adjusted for physical activity, energy intake and BMI in Model 3; fat intake (g day21), polyunsaturated fat/saturated fat ratio and alcohol intake (units week21) in Model 4; and addition-
ally for smoking, cholesterol intake (mg day21) and monounsaturated fat intake (g day21) in Model 5 and Englyst fibre (g day21) in Model 6.
†† TAG is adjusted for physical activity, energy intake and BMI in Model 3, as well as alcohol intake (units week21) in Model 4, carbohydrate intake (g day21) in Model 5 and Englyst fibre (g day21) in Model 6.
‡‡ For SBP and DBP, Model 3 is adjusted for physical activity, energy intake and BMI; in Model 4 alcohol intake (units week21) is added; Model 5 includes smoking status, polyunsaturated fat/saturated fat ratio and
cholesterol intake (mg day21); and Englyst fibre (g day21) was added in Model 6.
JE
M
ilto
n
et
a
l.
1
3
3
0
Table 6 Results of the linear regression analysis of GI and CVD risk factors in females
Model 1† Model 2‡ Model 3 Model 4 Model 5 Model 6
B ^ SE P B ^ SE P B ^ SE P B ^ SE P B ^ SE P B ^ SE P
Weight§ 20.061 ^ 0.156 0.70 20.049 ^ 0.156 0.75 20.086 ^ 0.157 0.58 20.084 ^ 0.157 0.60 20.089 ^ 0.167 0.60
BMI§ 0.028 ^ 0.061 0.65 0.020 ^ 0.063 0.75 0.013 ^ 0.063 0.84 0.009 ^ 0.064 0.89 20.005 ^ 0.068 0.94
WHR§ 0.001 ^ 0.001 0.33 0.001 ^ 0.001 0.42 0.001 ^ 0.001 0.45 0.001 ^ 0.001 0.46 0.000 ^ 0.001 0.94
TC{ 0.009 ^ 0.022 0.68 0.009 ^ 0.023 0.71 0.009 ^ 0.023 0.71 0.007 ^ 0.023 0.76 0.006 ^ 0.024 0.80 0.009 ^ 0.026 0.73
LDL-C{ 0.013 ^ 0.022 0.56 0.011 ^ 0.023 0.63 0.010 ^ 0.023 0.65 0.009 ^ 0.023 0.71 0.007 ^ 0.024 0.78 0.009 ^ 0.026 0.73
þ HDL-Ck ,0.001 ^ 0.002 0.92 0.001 ^ 0.002 0.76 0.001 ^ 0.002 0.68 0.001 ^ 0.002 0.62 0.001 ^ 0.002 0.63 0.002 ^ 0.002 0.42
þ TC/HDL-C ratiok ,0.001 ^ 0.002 0.87 20.001 ^ 0.002 0.82 20.001 ^ 0.002 0.76 20.001 ^ 0.003 0.66 20.001 ^ 0.003 0.74 20.001 ^ 0.003 0.59
þ TAG†† 0.004 ^ 0.003 0.10 0.003 ^ 0.003 0.36 0.002 ^ 0.003 0.47 0.002 ^ 0.003 0.47 0.002 ^ 0.003 0.47 0.001 ^ 0.003 0.86
SBP‡‡ 0.210 ^ 0.322 0.52 0.110 ^ 0.329 0.74 0.165 ^ 0.329 0.62 0.159 ^ 0.329 0.63 0.209 ^ 0.332 0.53 0.159 ^ 0.361 0.66
DBP‡‡ 20.075 ^ 0.183 0.68 20.116 ^ 0.188 0.54 20.126 ^ 0.189 0.51 20.126 ^ 0.190 0.51 20.083 ^ 0.190 0.66 20.122 ^ 0.207 0.56
GI – glycaemic index; CVD – cardiovascular disease; SE – standard error; BMI – body mass index; WHR – waist-to-hip ratio; TC – total cholesterol; LDL-C – low-density lipoprotein cholesterol; HDL-C – high-
density lipoprotein cholesterol; TAG – triacylglycerols; SBP – systolic blood pressure; DBP – diastolic blood pressure.
þ indicates dependent variables that were log-transformed to normalise before use in regression analysis.
† Model 1 shows unadjusted influence of GI on dependent variable.
‡ Model 2, for all variables, is adjusted for age, social class and region.
§ For weight, BMI and WHR, Model 3 is adjusted for physical activity and energy intake; fat (g day21) is added to Model 4; and Englyst fibre (g day21) to Model 5.
{For TC and LDL-C, Model 3 is adjusted for physical activity, energy intake and BMI; Model 4 is additionally controlled for fat intake (g day21); smoking, polyunsaturated fat/saturated fat ratio, cholesterol intake
(mg day21) and trans fatty acids (g day21) are added in Model 5; and Engylst fibre (g day21) in Model 6.
kHDL-C and TC/HDL-C ratio are adjusted for physical activity, energy intake and BMI in Model 3; fat intake (g day21), polyunsaturated fat/saturated fat ratio and alcohol intake (units week21) in Model 4; and addition-
ally for smoking, cholesterol intake (mg day21) and monounsaturated fat intake (g day21) in Model 5 and Englyst fibre (g day21) in Model 6.
†† TAG is adjusted for physical activity, energy intake and BMI in Model 3, as well as alcohol intake (units week21) in Model 4, carbohydrate intake (g day21) in Model 5 and Englyst fibre (g day21) in Model 6.
‡‡ For SBP and DBP, Model 3 is adjusted for physical activity, energy intake and BMI; in Model 4 alcohol intake (units week21) is added; Model 5 includes smoking status, polyunsaturated fat/saturated fat ratio and
cholesterol intake (mg day21); and Englyst fibre (g day21) was added in Model 6.
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diastolic BP in males. In the combined analysis of both
sexes the association with TAG persisted and a direct
relationship between GI and WHR was identified. These
relationships were attenuated by increasing levels of
adjustment for potential confounding factors, and became
statistically non-significant. No significant relationships
were observed for weight, BMI or lipoprotein
concentrations.
Previous intervention studies investigating the efficacy
of high- vs. low-GI diets for weight loss report conflicting
findings18,19. Liese et al. studied 979 normal (67%) and
‘glucose tolerance impaired’ (33%) adults and found no
association between GI (as assessed by food-frequency
questionnaire, FFQ) and BMI or waist circumference28.
This lack of association was attributed to the sample size
and the exclusion of people with pre-existing CVD or
diabetes, thus resulting in a cohort less susceptible to
environmental exposure13. In contrast, Ma et al. found a
direct association between GI (7-day dietary recall) and
BMI in a longitudinal study of 572 healthy adults27. Other
studies have found significant, direct relationships
between GI and weight, yet these tend to include obese
individuals or younger adults49,50. Fat mass increases and
lean mass decreases with age, independent of body
weight change. This change comprises increases in
visceral adipose tissue, intramyocellular and intramuscular
lipid and liver fat, and decreases in lean soft tissue and in
fat-free mass51. These changes may render an elderly
population less responsive to dietary changes and
comparisons of studies with different population ages
invalid.
Ingestion of high-GI carbohydrates results in reduced
insulin sensitivity, and potentially a reduction in HDL-C
and reciprocal increase in TAG concentration52. Low-GI
diets improve insulin sensitivity53, therefore higher HDL-C
and lower TAG concentrations might be expected in
individuals following such diets. Unlike previous popu-
lation studies23,26, we failed to observe an association
between dietary GI and HDL-C. Our results are consistent
with those from the Zutphen Elderly Study25, which
examined the association between high-GI diets and
hyperinsulinaemia, hyperglycaemia, dyslipidaemia and
CHD risk in 394 males (64–84 years). The lack of
association was attributed to the exclusion of males with a
history of diabetes or myocardial infarction13; however, no
such exclusions were applied here. The disparity in age
may explain these differences, as TC and LDL-C levels
have been shown to increase54, while fractional clearance
of LDL-C55 and the number of LDL receptors in hepatic
tissue decline56, with age.
TheNDNS had a low response rate (,50%), resulting in a
sample size half that estimated to observe significant
associations, and one potentially biased by differences in
diet, lifestyle and CVD risk factors between responders and
non-responders. A high proportion of LERs (40% males,
60% females) was identified and insufficient information is
available to determine whether under- or misreporting was
evident, or if reported low intakes were valid. Under-
reporting may not affect foods or nutrients system-
atically57,58; thus, although energy adjustment controls for
differences in energy intake, percentage intakes from
macronutrients may remain inaccurate. Protein intake was
validated in the NDNS feasibility study through compari-
sons of urinary with dietary nitrogen concentrations;
however, no biomarkers exist for carbohydrate or fibre and
therefore validation of GI calculations is not routine.
Our dietary GI values ranged from 40 to 72 units
(glucose ¼ 100), with a normal distribution. In the
Zutphen study25 values ranged from 39 to 65 units, with
a right skewed distribution. Frost et al.23 previously
associated low-GI diets with higher HDL-C concentrations
in healthy middle-aged adults. The total range of GI was
not presented, however data were normally distributed
and quintile means were similar to those of the current
study. The lack of variation in dietary GI is unlikely to be
responsible for the lack of association observed here;
therefore GI calculation estimates were considered. The
majority of values were obtained from international
tables38, many of which are sourced outside the UK; thus
estimates for processed foods (e.g. Special K) may be
invalid. Between-subject variation (for example, between
diabetic and non-diabetic test groups)59, methodological
differences, and differences in preparation, processing,
variety and ripeness may also introduce inaccuracies.
Using the mean of multiple estimates, we attempted to
improve the reliability of GI estimates, but undoubtedly
inaccuracies remain that could attenuate observed
associations60.
GI values estimated from analogues contributed to
approximately 26% carbohydrate. Where recipes and
mixed-meal calculations are used, effects of protein and fat
from non-carbohydrate-containing foods on insulin
secretion or gastric emptying are ignored61. One study of
eight healthy subjects demonstrated that variations in the
energy (395–610 kcal), fat (8–24 g) and protein (12–25g)
content of ameal have little effect on thepostprandial insulin
andglucose response62, the amountof carbohydrate and the
GI explaining 90% of the observed variation in glucose
response. Flint et al.41 disagree however. Their study of 28
subjects consuming 13 test meals found no association
between the estimated GI and that obtained using in vivo GI
measurements. The meals all contained 50g available
carbohydrate with varying amounts of fibre (1–24g), fat
(3–42 g) and protein (5–28g), and hence differing energy
contents (270–715kcal)41.
The current study is limited by its cross-sectional design.
We are trying to detect true associations between dietary
intake estimated from a 4-day record (which may or may
not represent long-term habitual intake) and various CVD
risk factors, which may have been influenced by diet for
more than 60 years, and which are also subject to other
environmental63 and genetic64 influences. Notably, dietary
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intakes differ between adulthood and old age due to
changes in physiology, dentition, and intended weight
gain or loss. Problems with dentition may cause elderly
individuals to eat softer, lower-fibre foods (e.g. white
bread (GI ¼ 70) vs. grainy/seeded bread (GI ¼ 54)) and
could explain why our results do not support those of
other studies; however, no food group analysis was
completed here.
The physiological changes associated with ageing might
limit or mask the beneficial effect of low-GI diets on body
weight or CVD risk factors. The prospective Nurses’ Health
Study investigated the effect of GI on CVD risk24 among
.75 000 US women followed-up for 10 years. The highest
quintile of GI (assessed by FFQ, relative to the lowest
category) was associated with a relative risk of 1.28
(P ¼ 0.02) for total CHD. We have examined risk factors
for CVD independently and found no significant beneficial
effect; however, small additive effects (undetectable in an
epidemiological study of this size) on individual risk
factors might combine to produce a measurable effect on
disease incidence in the long term.
Our results provide limited evidence for a beneficial
effect of low-GI diets with regard to body weight, BMI
or CVD risk factors in an older British population. The
relationship between GI and CVD risk may not exist in
this population, or may be confounded by factors such
as pre-existing CVD (58% taking cardiovascular medi-
cations) or diabetes (15% taking endocrine medi-
cations). Furthermore, regression analyses may be
under-powered and subject to attenuation of dietary
GI–CVD risk factor associations, the result of regression
dilution bias introduced by unreliable dietary GI
estimates60.
No data are available on frequencies of individual or
groups of foods consumed. Dairy products and high-fibre
foods have low GI38, but may affect anthropometric
variables, BP or dyslipidaemia differently due to variability
in fibre, micronutrient, antinutrient and antioxidant levels
for example. Our final regression analysis found
interactions between fibre and GI in some outcome
variables, indicating that a high dietary GI may be more
important in low- compared with high-fibre diets. The
interrelationships between GI, fibre and CVD risk warrant
further research. A factorial RCT could provide key
carbohydrate-containing foods and compare the CVD risk
profiles of four groups following combinations of low- or
high-GI and low- or high-fibre diets. Alternatively, large
RCTs could be used to examine the effect of GI on
anthropometric and CVD risk factors, while prospective
studies assessing food intake longitudinally with anthro-
pometric, biochemical and CVD outcomes would be
informative.
This study shows some associations between dietary GI
and measures of obesity, BP and lipoprotein profile in an
older British population, prior to adjusting for potential
confounding factors. However, there is very limited
evidence in an elderly population to justify advice to
lower dietary GI for CVD prevention.
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